12/17
07:32 am
tlsa
Tiziana Life Sciences Announces First Patient with Moderate Alzheimer's Disease Dosed with Intranasal Foralumab [Yahoo! Finance]
Low
Report
Tiziana Life Sciences Announces First Patient with Moderate Alzheimer's Disease Dosed with Intranasal Foralumab [Yahoo! Finance]
12/17
07:00 am
tlsa
Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab
Low
Report
Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab
12/4
07:15 am
tlsa
Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers [Yahoo! Finance]
Low
Report
Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers [Yahoo! Finance]
12/4
07:00 am
tlsa
Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers
Low
Report
Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers
11/19
07:06 am
tlsa
Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association [Yahoo! Finance]
Medium
Report
Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association [Yahoo! Finance]
11/19
07:00 am
tlsa
Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
Medium
Report
Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
11/1
01:00 pm
tlsa
Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data
Low
Report
Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data
10/30
10:36 pm
tlsa
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million [Yahoo! Finance]
High
Report
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million [Yahoo! Finance]
10/30
10:29 pm
tlsa
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million
High
Report
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million
10/30
08:30 am
tlsa
Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study
Medium
Report
Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study
10/20
07:30 am
tlsa
Tiziana Life Sciences Advances with Promising Drug Trials [Yahoo! Finance]
Low
Report
Tiziana Life Sciences Advances with Promising Drug Trials [Yahoo! Finance]